内脏肥胖及其相关疾病的最新进展
Recent Advances in Visceral Obesity and Related Diseases
DOI: 10.12677/ACM.2022.12121684, PDF,   
作者: 魏佳佳, 缪 巍*:青海大学附属医院,青海 西宁
关键词: 内脏肥胖VFA评估指标最新进展Visceral Obesity VFA Evaluation Indicators Recent Progress
摘要: 肥胖是一种病因多面的复杂疾病,具有自身的致残能力、病理生理学和共病,也可定义为是一种与特定身材、性别和年龄的期望值相比,伴随过度脂肪沉积的一种病理状态。而由肥胖导致的相关疾病对人们的工作、生活及心理等均造成了影响,使得人们生活质量进一步下降。随着对肥胖的越来越重视,目前已有多种评估肥胖的测量指标,不同评估指标有着各自的临床参考意义。而目前多项研究表明内脏脂肪面积(visceral fat area, VFA)作为内脏肥胖的测量指标,与一些内科基础疾病及外科手术疾病等有着密切的联系。本文综合目前国内外相关研究,将从肥胖的临床评估指标和与内脏肥胖相关的临床疾病的研究进展两方面作一综述。
Abstract: Obesity is a complex disease of multifaceted aetiology, with its own disabling capacities, pathophysiologies and comorbidities. It can also be defined as a pathological condition accompanied by excessive fat deposition compared to the expectations of a specific body, sex and age. The related diseases caused by obesity have an impact on people’s work, life and psychology, which further reduces people’s quality of life. With the increasing attention to obesity, there are a variety of measurement indicators for assessing obesity, and different evaluation indicators have their own clinical reference significance. At present, a number of studies have shown that visceral fat area (VFA) as a measurement index of visceral obesity is closely related to some basic diseases of internal medicine and surgical diseases. Based on the current relevant research at home and abroad, this article will review the clinical evaluation indicators of obesity and the research progress of clinical diseases related to visceral obesity.
文章引用:魏佳佳, 缪巍. 内脏肥胖及其相关疾病的最新进展[J]. 临床医学进展, 2022, 12(12): 11686-11693. https://doi.org/10.12677/ACM.2022.12121684

参考文献

[1] Finelli, C., Sommella, L., Gioia, S., La Sala, N. and Tarantino, G. (2013) Should Visceral Fat Be Reduced to Increase Longevity? Ageing Research Reviews, 12, 996-1004. [Google Scholar] [CrossRef] [PubMed]
[2] 倪国华, 张瞡, 郑风田. 中国肥胖流行的现状与趋势[J]. 中国食物与营养, 2013, 19(10): 70-74.
[3] Burkhauser, R.V. and Cawley, J. (2008) Beyond BMI: The Value of More Accurate Measures of Fatness and Obesity in Social Science Research. Journal of Health Economics, 27, 519-529. [Google Scholar] [CrossRef] [PubMed]
[4] Gutin, I. (2018) In BMI We Trust: Reframing the Body Mass Index as a Measure of Health. Social Theory & Health, 16, 256-271. [Google Scholar] [CrossRef] [PubMed]
[5] Ross, R., Neeland, I.J., Yamashita, S., et al. (2020) Waist Circumference as a Vital Sign in Clinical Practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nature Reviews Endocrinology, 16, 177-189. [Google Scholar] [CrossRef] [PubMed]
[6] Kissebah, A.H., et al. (1982) Relation of Body Fat Distribution to Metabolic Complications of Obesity. The Journal of Clinical Endocrinology & Metabolism, 54, 254-260. [Google Scholar] [CrossRef] [PubMed]
[7] Ashwell, M., Lejeune, S. and McPherson, K. (1996) Ratio of Waist Circumference to Height May Be Better Indicator of Need for Weight Management. BMJ, 312, 377. [Google Scholar] [CrossRef] [PubMed]
[8] 郑邦伟. 浅析腹型肥胖对人体健康的危害[J]. 中西医结合心血管病电子杂志, 2018, 6(11): 195-196.
[9] Anari, R., Amani, R., Latifi, S.M., et al. (2017) Association of Obesity with Hypertension and Dyslipidemia in Type 2 Diabetes Mellitus Subjects. Diabetes & Metabolic Syndrome, 11, 37-41. [Google Scholar] [CrossRef] [PubMed]
[10] Lee, M.J., Wu, Y. and Fried, S.K. (2013) Adipose Tissue Hetero-geneity: Implication of Depot Differences in Adipose Tissue for Obesity Complications. Molecular Aspects of Medicine, 34, 1-11. [Google Scholar] [CrossRef] [PubMed]
[11] 姜勇. 我国成人超重肥胖流行现状、变化趋势及健康危害研究[D]: [博士学位论文]. 北京: 中国疾病预防控制中心, 2013.
[12] Tchernof, A. and Després, J.P. (2013) Patho-physiology of Human Visceral Obesity: An Update. Physiological Reviews, 93, 359-404. [Google Scholar] [CrossRef] [PubMed]
[13] Frank B. Hu. 中国肥胖与2型糖尿病的发病趋势及其政策的影响[J]. 中华内科杂志, 2014, 53(1): 5-8.
[14] Brown, E., Wilding, J.P.H., Barber, T.M., Alam, U. and Cuthbertson, D.J. (2019) Weight Loss Variability with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus and Obesity: Mechanistic Possibilities. Obesity Reviews, 20, 816-828. [Google Scholar] [CrossRef] [PubMed]
[15] 赵楠, 许杰, 李晓晨, 等. 腹部脂肪分布对2型糖尿病患者人体成分及胰岛功能的影响[J]. 国际内分泌代谢杂志, 2019, 39(6): 361-367.
[16] Lv, X., Zhou, W., Sun, J., et al. (2017) Visceral Adiposity Is Significantly Associated with Type 2 Diabetes in Middleaged and Elderly Chinese Women: A Cross-Sectional Study. Journal of Diabetes, 9, 9208. [Google Scholar] [CrossRef] [PubMed]
[17] Neeland, I.J., Turer, A.T., Ayers, C.R., et al. (2012) Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults. JAMA, 308, 1150-1159. [Google Scholar] [CrossRef] [PubMed]
[18] Boyko, E.J., Fujimoto, W.Y., Leonetti, D.L. and Newell-Morris, L. (2000) Visceral Adiposity and Risk of Type 2 Diabetes: A Prospective Study among Japanese Americans. Diabetes Care, 23, 465-471. [Google Scholar] [CrossRef] [PubMed]
[19] Kim, E.H., Kim, H.K., Lee, M.J., Bae, S.J., et al. (2022) Sex Dif-ferences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal, 46, 486-498. [Google Scholar] [CrossRef] [PubMed]
[20] Epingeac, M.E., Gaman, M.A., Diaconu, C.C., et al. (2019) The Evaluation of Oxidative Stress Levels in Obesity. Revista De Chimie, 70, 2241-2244. [Google Scholar] [CrossRef
[21] Gaman, M.-A.D., Pascu, E.-C., Cozma, E.G., et al. (2019) Cardio Metabolic Risk Factors for Atrial Fibrillation in Type 2 Diabetes Mellitus: Focus on Hypertension, Metabolic Syndrome and Obesity. Journal of Mind and Medical Sciences, 6, 24. [Google Scholar] [CrossRef
[22] Liu, S., Li, Y., Zeng, X., et al. (2019) Burden of Cardiovascular Diseases in China, 1990-2016: Findings from the 2016 Global Burden of Disease Study. JAMA Cardiology, 4, 342-352. [Google Scholar] [CrossRef] [PubMed]
[23] Deng, J., Hu, X., Xiao, C., et al. (2020) Ambient Temperature and Non-Accidental Mortality: A Time Series Study. Environmental Science and Pollution Research (International), 27, 4190-4196. [Google Scholar] [CrossRef] [PubMed]
[24] Ford, E.S., Ajani, U.A., Croft, J.B., et al. (2007) Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980-2000. The New England Journal of Medicine, 356, 2388-2398. [Google Scholar] [CrossRef
[25] Artinian, N.T., Fletcher, G.F., Mozaffarian, D., Kris-Etherton, P., Van Horn, L., Lichtenstein, A.H., et al. (2010) Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults a Scientific Statement from the American Heart Association. Circulation, 122, 406-441. [Google Scholar] [CrossRef
[26] Gruzdeva, O., Borodkina, D., Uchasova, E., Dyleva, Y. and Barbarash, O. (2018) Localization of Fat Depots and Cardiovascular Risk. Lipids in Health and Disease, 17, 218. [Google Scholar] [CrossRef] [PubMed]
[27] Neeland, I.J., Ross, R., Després, J.P., et al. (2019) Visceral and Ectopic Fat, Atherosclerosis, and Cardiometabolic Disease: A Position Statement. The Lancet Diabetes & Endocrinology, 7, 715-725. [Google Scholar] [CrossRef
[28] 张姝嫔, 程成, 祝怡婕, 等. 超声衰减成像定量诊断非酒精性脂肪肝的应用价值初探讨[J]. 中国超声医学杂志, 2021, 37(1): 66-69.
[29] Lee, S.W., Lee, T.Y., Yang, S.S., Tung, C.F., Yeh, H.Z. and Chang, C.S. (2018) Risk Factors and Metabolic Abnormality of Patients with Non-Alcoholic Fatty Liver Disease: Either Non-Obese or Obese Chinese Population. Hepatobiliary & Pancreatic Diseases International, 17, 45-48. [Google Scholar] [CrossRef] [PubMed]
[30] Fox, C.S., Massaro, J.M., Hoffmann, U., et al. (2007) Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association with Metabolic Risk Factors in the Framingham Heart Study. Circulation, 116, 39-48. [Google Scholar] [CrossRef
[31] Chen, T.P., Lin, W.Y., Chiang, C.H., Shen, T.H., Huang, K.C. and Yang, K.C. (2021) Metabolically Healthy Obesity and Risk of Non-Alcoholic Fatty Liver Disease Severity Independent of Visceral Fat. Journal of Gastroenterology and Hepatology, 36, 2903-2910. [Google Scholar] [CrossRef] [PubMed]
[32] 刘海泽, 范海楠, 李丹丹, 汪丽彬. 40岁以上人群内脏脂肪面积与非酒精性脂肪肝的相关性研究[C]//中国体育科学学会. 第十二届全国体育科学大会论文摘要汇编——专题报告(体质与健康分会). 2022: 20-21.
[33] 张伟, 刘新宇, 梁雪华, 邹德一, 曾丽萍. 内脏脂肪面积增大与非酒精性脂肪肝相关性的临床研究[J]. 岭南急诊医学杂志, 2018, 23(2): 130-132.
[34] 刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-13.
[35] 李雪, 闫雨萌, 平卫伟. 肥胖对消化道系统癌症发病影响的系统评价[J]. 中国循证医学杂志, 2022, 22(10): 1155-1160.
[36] 顾卫琼, 王卫庆. 肥胖与癌症关系及临床[J]. 中国实用内科杂志, 2011, 31(9): 684-686.
[37] Taniguchi, Y., Kurokawa, Y., Takahashi, T., et al. (2021) Impacts of Preoperative Psoas Muscle Mass and Visceral Fat Area on Postoperative Short- and Long-Term Outcomes in Patients with Gastric Cancer. World Journal of Surgery, 45, 815-821. [Google Scholar] [CrossRef] [PubMed]
[38] Ojima, T., Hayata, K., Kitadani, J., Takeuchi, A. and Yamaue, H. (2022) Risk Factors of Postoperative Intra-Abdominal Infectious Complications after Robotic Gastrectomy for Gastric Cancer. Oncology, 100, 583-590. [Google Scholar] [CrossRef
[39] Takeuchi, M., Ishii, K., Seki, H., Yasui, N., Sakata, M., Shimada, A. and Matsumoto, H. (2016) Excessive Visceral Fat Area as a Risk Factor for Early Postoperative Complications of Total Gastrectomy for Gastric Cancer: A Retrospective Cohort Study. BMC Surgery, 16, Article No. 54. [Google Scholar] [CrossRef] [PubMed]
[40] Imai, Y., Lee, S.W., Kawai, M., Tashiro, K., et al. (2022) Visceral Fat Area Is a Better Indicator of Surgical Outcomes after Laparoscopic Gastrectomy for Cancer than the Body Mass Index: A Propensity Score-Matched Analysis. Surgical Endoscopy, 36, 3285-3297. [Google Scholar] [CrossRef] [PubMed]
[41] 李啸文, 仇广林, 王海江, 王盼兴, 刘家煌, 朱梦珂, 廖新华, 樊林, 车向明. 内脏脂肪面积对胃癌根治术患者预后的影响[J]. 西安交通大学学报(医学版), 2022, 43(3): 419-425.
[42] Yang, S.J., Li, H.R., Zhang, W.H., et al. (2020) Visceral Fat Area (VFA) Superior to BMI for Predicting Postoperative Complications after Radical Gastrectomy: A Prospective Cohort Study. Journal of Gastrointestinal Surgery, 24, 1298-1306. [Google Scholar] [CrossRef] [PubMed]
[43] Silva, A., Faria, G., Araújo, A. and Monteiro, M.P. (2020) Impact of Adiposity on Staging and Prognosis of Colorectal Cancer. Critical Reviews in On-cology/Hematology, 145, Article ID: 102857. [Google Scholar] [CrossRef] [PubMed]
[44] Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2020) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. [Google Scholar] [CrossRef] [PubMed]
[45] Aleksandrova, K., Boeing, H., Jenab, M., et al. (2011) Metabolic Syn-drome and Risks of Colon and Rectal Cancer: The European Prospective Investigation into Cancer and Nutrition Study. Cancer Prevention Research, 4, 1873-1883. [Google Scholar] [CrossRef
[46] Watanabe, J., Tatsumi, K., Ota, M., et al. (2014) The Impact of Visceral Obesity on Surgical Outcomes of Laparoscopic Surgery for Colon Cancer. International Journal of Colorectal Disease, 29, 343-351. [Google Scholar] [CrossRef] [PubMed]
[47] Cakir, H., Heus, C., Verduin, W.M., et al. (2015) Visceral Obe-sity, Body Mass Index and Risk of Complications after Colon Cancer Resection: A Retrospective Cohort Study. Surgery, 157, 909-915. [Google Scholar] [CrossRef] [PubMed]
[48] 冯哲文, 田名伟, 寇天阔, 李东明, 宋建宁, 杨鋆, 杨盈赤, 张忠涛. 内脏脂肪组织与结直肠癌发病风险及预后关系研究进展[J]. 中国实用外科杂志, 2022, 42(8): 953-957.
[49] Ono, T., Murakoshi, M., Suzuki, N., Iida, N., Ohdera, M., Iigo, M., Yoshida, T., Sugiyama, K. and Ni-shino, H. (2010) Potent Anti-Obesity Effect of Enteric-Coated Lactoferrin: Decrease in Visceral Fat Accumulation in Japanese Men and Women with Abdominal Obesity after 8-Week Administration of Enteric-Coated Lactoferrin Tablets. British Journal of Nutrition, 104, 1688-1695. [Google Scholar] [CrossRef
[50] Ono, T., Morishita, S., Fujisaki, C., Ohdera, M., Murakoshi, M., Iida, N., Kato, H., Miyashita, K., Iigo, M., Yoshida, T., Sugiyama, K. and Nishino, H. (2011) Effects of Pepsin and Trypsin on the Anti-Adipogenic Action of Lactoferrin against Preadipocytes Derived from Rat Mesenteric Fat. British Journal of Nutrition, 105, 200-211. [Google Scholar] [CrossRef
[51] Finelli, C. and Tarantino, G. (2013) What Is the Role of Adiponectin in Obesity Related Nonalcoholic Fatty Liver Disease? World Journal of Gastroenterology, 19, 802-812. [Google Scholar] [CrossRef] [PubMed]
[52] 曲建娇, 金雪雁. 利拉鲁肽减少内脏脂肪的研究进展[J]. 中国社区医师, 2016, 32(22): 13-14.
[53] 日本发现中国的恒顺香醋可减少内脏脂肪[J]. 中国食品学报, 2016, 16(8): 177.
[54] 梁绮君, 胡晨鸣, 黄容, 陈瑞珠, 赖锦兰, 黎慧萍, 李东彩, 余寿益. 山楂消脂胶囊对肥胖症患者内脏脂肪的影响[J]. 广东医学, 2016, 37(17): 2669-2671.
[55] Bendall, C.L., Mayr, H.L., Opie, R.S., Bes-Rastrollo, M., Itsiopoulos, C. and Thomas, C.J. (2018) Central Obesity and the Mediterranean Diet: A Systematic Review of Inter-vention Trials. Critical Reviews in Food Science and Nutrition, 58, 3070-3084. [Google Scholar] [CrossRef] [PubMed]
[56] Leidy, H.J., Clifton, P.M., Astrup, A., Wycherley, T.P., Westerterp-Plantenga, M.S., Luscombe-Marsh, N.D., Woods, S.C. and Mattes, R.D. (2015) The Role of Protein in Weight Loss and Maintenance. The American Journal of Clinical Nutrition, 101, 1320S-1329S. [Google Scholar] [CrossRef] [PubMed]